Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.91% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.04% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
1201
Stitch Fix
SFIX
$499M
| $6.95M | ﹤0.01% |
256,146
+40,865
| +19% | +$1.05M |
|
1202
CALL
ServiceNow
NOW
$132B
| $6.94M | ﹤0.01% |
71,500
-9,500
| -12% | -$848K |
|
1203
Turning Point Brands
TPB
$1.77B
| $6.93M | ﹤0.01% |
248,527
+23,779
| +11% | +$699K |
|
1204
Neurocrine Biosciences
NBIX
$16.5B
| $6.92M | ﹤0.01% |
71,979
+28,431
| +65% | +$3.29M |
|
1205
Teva Pharmaceuticals
TEVA
$42.5B
| $6.92M | ﹤0.01% |
767,485
+42,394
| +6% | +$448K |
|
1206
Nutanix
NTNX
$17.4B
| $6.91M | ﹤0.01% |
311,397
+137,302
| +79% | +$3.14M |
|
1207
TripAdvisor
TRIP
$1.28B
| $6.87M | ﹤0.01% |
350,950
+75,315
| +27% | +$1.58M |
|
|
SBNY
1208
DELISTED
Signature Bank
SBNY
| $6.87M | ﹤0.01% |
82,754
-1,618
| -2% | -$161K |
|
1209
Enphase Energy
ENPH
$5.59B
| $6.86M | ﹤0.01% |
83,103
-57,554
| -41% | -$3.85M |
|
1210
Bloomin' Brands
BLMN
$952M
| $6.85M | ﹤0.01% |
448,667
-30,081
| -6% | -$389K |
|
1211
PUT
Gilead Sciences
GILD
$168B
| $6.84M | ﹤0.01% |
108,200
-1,600
| -1% | -$111K |
|
1212
PUT
Microchip Technology
MCHP
$44B
| $6.82M | ﹤0.01% |
132,800
| – | – |
|
1213
Molina Healthcare
MOH
$10.2B
| $6.82M | ﹤0.01% |
37,235
+8,602
| +30% | +$1.57M |
|
|
XEC
1214
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $6.79M | ﹤0.01% |
279,200
+200
| +0.1% | +$5.27K |
|
1215
Neogen
NEOG
$2.51B
| $6.79M | ﹤0.01% |
173,570
+76,116
| +78% | +$2.91M |
|
1216
CALL
MGM Resorts International
MGM
$11.1B
| $6.77M | ﹤0.01% |
311,200
-28,800
| -8% | -$571K |
|
1217
Monolithic Power Systems
MPWR
$68.9B
| $6.77M | ﹤0.01% |
24,193
-1,187
| -5% | -$309K |
|
1218
PUT
Zillow
Z
$7.68B
| $6.76M | ﹤0.01% |
66,500
-42,800
| -39% | -$3.34M |
|
1219
Nordson
NDSN
$17.3B
| $6.75M | ﹤0.01% |
35,169
+13,498
| +62% | +$2.6M |
|
1220
CALL
Check Point Software Technologies
CHKP
$13.2B
| $6.74M | ﹤0.01% |
56,000
-11,600
| -17% | -$1.42M |
|
1221
PUT
Stanley Black & Decker
SWK
$15.7B
| $6.73M | ﹤0.01% |
41,500
+32,500
| +361% | +$5.06M |
|
1222
Markel Group
MKL
$22.8B
| $6.71M | ﹤0.01% |
6,893
+924
| +15% | +$939K |
|
1223
AngloGold Ashanti
AU
$49.3B
| $6.71M | ﹤0.01% |
254,188
+44,512
| +21% | +$1.33M |
|
1224
Lennox International
LII
$14.9B
| $6.67M | ﹤0.01% |
24,465
-4,106
| -14% | -$1.1M |
|
1225
Olin
OLN
$2.17B
| $6.66M | ﹤0.01% |
538,134
-60,640
| -10% | -$701K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.